Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-Specific Neoantigen (Frameshift Peptide) (Frameshift Peptide Neoantigen)
- Target
- Frameshift Peptide Neoantigen
- Molecular classification
- Peptide, Antigen, Neoantigen
01
Overview
Tumor-specific neoantigen (frameshift peptide) refers to unique protein fragments generated exclusively within tumors due to coding region insertions/deletions that shift the genetic reading frame. These highly immunogenic antigens serve as ideal targets for next-generation cancer immunotherapies because they are absent from normal tissues, reducing autoimmune risk while enabling precise immune targeting against malignant cells.
- Other names
- Frameshift-derived NeoantigenTumor-specific Frameshift PeptideNeoantigen (Frameshift)FS Neoantigen
02
Mechanism of action
Presentation on MHC-I molecules, leading to T cell receptor recognition and T cell-mediated cytotoxicity
03
Biological functions
Immune recognitionT cell activationAntigen presentation
04
Disease associations
CancerTumor immunology
05
Safety considerations
Potential for off-target effects (though minimized due to tumor specificity)Immune-related adverse events (irAEs)Tumor immune escape
06
Interacting drugs
Personalized cancer vaccines (mRNA/DNA/peptide)
2 more in the full profile.
07
Biomarkers
Neoantigen burdenMHC-I expressionT cell infiltrationFrameshift mutation presence
Beyond the preview
Go deeper on Tumor-Specific Neoantigen (Frameshift Peptide) (Frameshift Peptide Neoantigen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor-Specific Neoantigen (Frameshift Peptide) (Frameshift Peptide Neoantigen).